GPhC warns online pharmacies: Don't 'unjustifiably' inflate HRT prices

Online pharmacies should “make sure” they do not increase the prices of hormone replacement therapy (HRT) products “in a way that is unjustifiable”, General Pharmaceutical Council (GPhC) CEO Duncan Rudkin has told C+D. 

exclusive
HRT shortages
MP Carolyn Harris claimed that some online pharmacies are “profiteering” off HRT product shortages

The regulator recognises that women trying to obtain HRT medicines via private prescriptions might end up paying more than the NHS prescription charge “due to the costs involved in providing this service”, Mr Rudkin told C+D today (May 4).

However, the GPhC urged online pharmacies to be reasonable if they choose to raise the price of HRT products.

“We know that pharmacy teams across Great Britain are working very hard to try and get their patients the medicines they need,” he added.

Read more: MP to 'name and shame' online pharmacies over HRT drug prices

The GPhC’s comments follow Labour MP Carolyn Harris’s claim that some online pharmacies are “profiteering” off current HRT product shortages by selling treatments for up to “three times as much as they’re worth”.

Unable to access the products through NHS prescriptions, many have tried to source HRT medicine online and encountered hefty price tags, the MP said.

CMA has a part to play

The GPhC noted that the Competition and Markets Authority (CMA) “also has a role to play” in ensuring businesses do not inflate HRT prices “as it works to ensure consumers get a good deal when buying goods and services, and that businesses operate within the law”.

Read more: Boots to cover HRT prescription costs for pharmacy team members

C+D has approached the CMA for comment.

The GPhC reminded online pharmacies to refer and adhere to its guidance for providing services at a distance, to ensure they are being provided safely and effectively.

In 2020, the GPhC and the CMA issued a joint warning to pharmacies after receiving reports that a “small minority” were trying to benefit from the COVID-19 pandemic by charging “unjustifiably high prices” for products including face masks, hand sanitiser, and paracetamol.

Read more: Legal view: How has the CMA cracked down on profiteering pharmacies?

GPhC welcomes HRT task force

The regulator also welcomed the implementation of a new government HRT task force in light of “shortages […] negatively affecting the health and wellbeing of women who are unable to access the medicines they have been prescribed”.

Read more: Pharmacists granted power to limit supply of 3 ‘high demand’ HRT products

Madelaine McTernan, who directs the government's vaccine task force, will also spearhead the HRT supply task force to address the shortages and “identify ways to support the HRT supply chain”, the Department of Health and Social Care wrote in a statement last week (April 29).

Ms McTernan is due to meet with health secretary Sajid Javid and HRT manufacturers tomorrow to discuss supply.

On Friday, serious shortage protocols were issued for three “high demand” HRT products, allowing pharmacists to supply the affected medicines according to the protocol rather than the written prescription, without having to seek permission from the prescriber.

Latest from News

GPhC and NHSE announce ‘unique’ new pharmacy tech fellowship

 
• By 

The GPhC has announced that it is “co-hosting a national pharmacy technician fellowship” with NHS England “for the first time”, with applications opening this month.

Pharmacy First consultation payment caps rise up to 94%

 
• By 

New caps on the maximum number of paid Pharmacy First consultations have begun this month, rising between 55% and 94% across different types of pharmacies.

Contract chaos: NPA issues pharmacy collective action ultimatum

 
• By 

The National Pharmacy Association (NPA) has warned that it will have “little choice but to advise pharmacies to take collective action later this month” if delays to the pharmacy contract negotiations continue.

More from Business

Pharmacy ‘may not survive winter’ as pharmacist MP urges govt to avoid 'past 14 years' of mistakes

 
• By 

CPE data shows 96% of pharmacy owners are “concerned” or “very concerned” that “their business may not survive this winter” as Sadik Al-Hassan MP is “eager to see this government avoid mistakes made during the past 14 years that have brought our sector to a crisis point”.

CVS slapped with nationwide lawsuit over ‘unlawful’ opioid prescriptions

 
• By 

The US DOJ has filed a lawsuit against CVS alleging its “actions helped to fuel the opioid crisis” as it “prioritized corporate profits over patient safety”.